Skip to main content
. Author manuscript; available in PMC: 2016 Sep 5.
Published in final edited form as: Mol Cell Endocrinol. 2015 May 29;412:73–84. doi: 10.1016/j.mce.2015.05.030

Figure 3. Effect of VEGF-165, VEGF-E and PlGF and the inhibition by VEGFR inhibitor on Cx43 phosphorylation.

Figure 3

NP-UAEC and P-UAEC (left and right graphs, respectively) were pretreated for 20 min with 1 uM VEGFR inhibitor, followed by a 30-min treatment with 10 ng/ml VEGF-165, 100 ng/ml VEGF-E or 100 ng/ml PlGF. Results were normalized to Hsp90 protein and expressed as fold change over unstimulated control. Phospho-specific western blot analyses were performed, and representative blots are shown. Values shown are Means ± S.E.M. of 6 independent experiments (* P<0.05 compared with control; + P<0.05 compared with same agonist treatment; # P<0.05 compared with NP-UAEC; § P<0.05 compared with VEGF-165 treatment). A. Response of Ser-279/282 Cx43. B. Response of Tyr-265 Cx43.